67 related articles for article (PubMed ID: 6732438)
1. Increased risk for cancer of the breast due to previous medication.
de Levin RW; Puig OR; Levin E
Arch Geschwulstforsch; 1984; 54(2):153-8. PubMed ID: 6732438
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Rauwolfia use and breast cancer: a case-control study.
Stanford JL; Martin EJ; Brinton LA; Hoover RN
J Natl Cancer Inst; 1986 May; 76(5):817-22. PubMed ID: 3457968
[TBL] [Abstract][Full Text] [Related]
4. Cimetidine use and risk of prostate and breast cancer.
Rossing MA; Scholes D; Cushing-Haugen KL; Voigt LF
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):319-23. PubMed ID: 10750671
[TBL] [Abstract][Full Text] [Related]
5. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer.
Coogan PF; Zhang Y; Palmer JR; Strom BL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1012-5. PubMed ID: 15824181
[TBL] [Abstract][Full Text] [Related]
7. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
8. [Cancer risk under hormone therapy].
Lauritzen C
Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication use and risk of epithelial ovarian cancer.
Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
[TBL] [Abstract][Full Text] [Related]
10. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
Baumann M; Trincard M
Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
[TBL] [Abstract][Full Text] [Related]
11. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
13. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
14. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments.
Harvey PW
J Appl Toxicol; 2005; 25(3):179-83. PubMed ID: 15856525
[TBL] [Abstract][Full Text] [Related]
15. [Female sex hormones increase the risk of breast cancer].
Vatten L
Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
[TBL] [Abstract][Full Text] [Related]
16. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
18. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
19. [Oral contraceptive use and the risk of cancer].
Wingo PA
Fertil Contracept Sex; 1989 Feb; 17(2):125-32. PubMed ID: 12281877
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]